The USPTO issued Patent US12590111B2 granting Mühlbauer Technology GmbH exclusive rights to a flavonoid derivative composition for dental caries treatment. The invention consists of a flavonoid coupled to an alkylene group via an ether bond, with an adhesion group enabling attachment to dental surfaces, providing long-term suppression of biofilm formation. The patent application (No. 17637029) was filed on August 20, 2020, and contains 15 claims.

This patent grant establishes intellectual property protection for the assignee in the dental/pharmaceutical composition space. Competitors developing similar flavonoid-based dental treatments should conduct freedom-to-operate analyses. The assignee may pursue licensing opportunities or enforcement against infringing products. No immediate compliance actions are required by regulated entities unless they are actively developing competing products in this space.